Speaker Announcement
We are pleased to announce Eileen Dunne, PhD, Senior Director of Vaccines Real-World Evidence (RWE) and Epidemiology at Pfizer, New York, as a confirmed speaker at the Global Virtual Streptococcus Research Symposium, taking place April 27–28, 2026 (Eastern Time, USA).
Dr. Dunne’s presentation will highlight recent advances in understanding the epidemiology of Streptococcus pneumoniae serotypes and the impact of pneumococcal conjugate vaccines using real-world evidence. Her work integrates epidemiological surveillance, vaccine effectiveness studies, and population-level data to evaluate vaccine performance and inform public health strategies for pneumococcal disease prevention.
Dr. Eileen M. Dunne is an epidemiologist specializing in pneumococcal disease and vaccine evaluation. Her research spans global pneumococcal epidemiology, vaccine impact assessment, and the application of real-world data to guide immunization policy and infectious disease prevention strategies.
Dates: April 27–28, 2026
Format: Virtual – Eastern Time (US)
This conference is organized by Impact Research Communications (IRC)
More info: https://strep.ircconferences.net/ | Advances in Streptococcus Research
Join the meeting to learn how real-world epidemiological data are shaping the evaluation and future development of pneumococcal conjugate vaccines.
